Showing results (421-430 of 892) with videos related to

Sort By:
Pageof 90
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 31, 2013
The use of bulk segregant analysis to identify a RAPD marker linked to leaf rust resistance in barleyD M Poulsen, R J Henry, R P Johnston, et al.
International Journal of Epidemiology|February 3, 1998
Serum total cholesterol and risk of hospitalization, and death from respiratory diseaseC Iribarren, D R Jacobs, S Sidney, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 12, 2003
The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing countryHeather J. Zar, Patti Apolles, Andrew Argent, et al.
Respiratory Medicine|July 13, 2010
A one-year trial of tiotropium Respimat plus usual therapy in COPD patientsE D Bateman, D Tashkin, N Siafakas, et al.
The European Respiratory Journal|October 20, 2006
The correlation between asthma control and health status: the GOAL studyE D Bateman, J Bousquet, M L Keech, et al.
Allergy|July 1, 2008
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) studyE D Bateman, J Bousquet, W W Busse, et al.
Respiratory Medicine|March 21, 2003
The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthmaN Ringdal, A Eliraz, R Pruzinec, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 21, 2000
Guideline for the management of chronic asthma in adults--2000 update. South African Pulmonology Society Adult Asthma Working GroupU G Lalloo, E D Bateman, C Feldman, et al.
The Lancet. Respiratory Medicine|December 11, 2013
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group studyClaus F Vogelmeier, Eric D Bateman, John Pallante, et al.
The European Respiratory Journal|August 26, 2017
Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroidsEric D Bateman, Alfredo G Guerreros, Florian Brockhaus, et al.
Pageof 90